Amin Khan - Jun 12, 2023 Form 4 Insider Report for Icosavax, Inc. (ICVX)

Role
EVP, Head of Research & Dev.
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact
Stock symbol
ICVX
Transactions as of
Jun 12, 2023
Transactions value $
$0
Form type
4
Date filed
6/14/2023, 07:48 PM
Previous filing
Aug 8, 2022
Next filing
Feb 20, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICVX Stock Option (Right to Buy) Award $0 +180K $0.00 180K Jun 12, 2023 Common Stock 180K $10.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option will vest on June 12, 2024, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service through the applicable vesting date.